OGN:NYSE
Organon & Co
$13.90
arrow_upward
+0.11%(+0.015) 1D
$13.87
arrow_downward
-0.23% (-0.031)bedtimeAfter hours
Closed: Nov 12, 4:00:04 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OGN...
Open
$13.87
High
$13.90
Low
$13.87
Mkt. cap
3.65B
Avg. vol.
2.43M
Volume
2.90M
Dividend
0.58%
Quarterly dividend
$0.02
Ex-dividend date
Aug 14, 2026
P/E ratio
18.08
52-wk high
$13.90
52-wk low
$5.69
EPS
$0.77
Beta
1.53
Shares outstanding
262.62M
No. of employees
10K
Open
$13.87
High
$13.90
Low
$13.87
Mkt. cap
3.65B
Avg. vol.
2.43M
Volume
2.90M
Dividend
0.58%
Quarterly dividend
$0.02
Ex-dividend date
Aug 14, 2026
P/E ratio
18.08
52-wk high
$13.90
52-wk low
$5.69
EPS
$0.77
Beta
1.53
Shares outstanding
262.62M
No. of employees
10K
News stories
From web sources and news partners
GuruFocus
·
14 hours ago
Organon (OGN) to Present Phase 3 VTAMA Cream Analysis at ACAAI M
Yahoo Finance
·
2 days ago
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10K
Founded1923
HeadquartersJersey City, New Jersey, United States
SectorHealth Care
IndustryPharmaceutical industry
Websiteorganon.com